ArticleSensors (Basel, Switzerland)2026
Transparent Graphene Interfaces for Capacitive Recordings from hiPSC-Derived Cardiomyocyte Monolayers: A Proof-of-Concept Study.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Transparent conductive interfaces can enable optical pre-assessment of cardiac cell layers while remaining compatible with label-free electrophysiological recording. Here, we evaluated the integration of a monolayer graphene electrode into a capacitive recording platform for the analysis of human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) monolayers. hiPSC-CMs cultured on graphene sensors formed confluent, synchronously beating monolayers that could be assessed by light microscopy prior to recording. Capacitive current transients could be recorded from spontaneously beating hiPSC-CM monolayers, supporting the compatibility of transparent graphene interfaces with capacitive recordings from electrically active cardiac cell layers. Signal amplitude and waveform morphology varied across sensors, indicating that recording performance depended strongly on the cell-sensor interface, including cell attachment, monolayer integrity, and capacitive coupling at the sensing surface. A descriptive perturbation sequence using the hERG blocker dofetilide revealed changes in waveform morphology and beat timing across sequential recordings. However, the data do not allow firm attribution to a compound-specific effect and are not intended for quantitative pharmacological characterization. Overall, the results support graphene as a transparent conductive cell-sensor interface, which should be interpreted in the context of cell-substrate interactions at the sensing surface. Combining optical pre-assessment with functional capacitive readout may support integrated workflows. Further studies will be needed to differentiate material-, interface-, and recording-related contributions and to establish reliable conditions for reproducible and scalable recordings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.